|
|
|
| The resistance spectrum of escherichia coli in bloodstream infection |
1.Respiratory & Critical Care Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015; 2.Laboratory Diagnostic Centre, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015
|
|
| Cite this article: |
|
YAO Dan1,YU Fangyou2,HUANG Xiaoying1, et al. The resistance spectrum of escherichia coli in bloodstream infection[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2014, 44(12): 917-919.
|
|
|
Abstract Objective: To investigate the drug resistance of escherichia coli isolated from patients with bloodstream infection to commonly used antibiotics, and to provide reference for clinical anti-infective drug therapy. Methods: The France Bio-Merieux company VITEK-60 compact automatic bactecial identification instrument was employed to identify the bactecia. According to the (NCCLS) 2005, the double disk confirmatory test were adopted to detect ESBLs, and K-B disk diffusion assay was used to determine antibiotic resistance of escherichia coli. Results: Totally 175 strains of escherichia coli were isolated from the samples, among them, ESBLs-producing strains accounted for 52.6% (92/175). The drug resistence of ESBL-producing escherichia coli to ampicillin, cefazolin, ceftriaxone, ceftazidime were 98.9%, 97.8%, 94.6%, 83.7% respectively, which were significantly higher than that of non-ESBL-producing escherichia coli. The drug resistence of ESBL-producing escherichia coli to trimesulf, ciprofloxacin, gentamycin, tobramycin, levofloxacin were 76.1%, 57.6%, 57.6%, 58.7%, 69.6% respectively. The drug resistence rate to piperacillin tazobactam and macrodantin were almost similar in ESBL-producing escherichia coli and non-ESBL-producing escherichia coli. And the whole escherichia coli were sensitive to tienam and vancomycin. Conclusion: Escherichia coli as the major gram-negative bacterium led to bloodstream infection, its resistance phenomenon to common antibiotics was serious. It is necessary to pay more attention to the the drug resistance to provide reference for clinical anti-infective drug therapy.
|
|
Received: 15 July 2014
|
| |
|
|
|
[1]陆红, 朱丽青, 吴庆, 等. 血液感染大肠埃希菌的耐药性及其超广谱β-内酰胺酶分析[J]. 浙江检验医学, 2009(2): 54-56.
[2]马红英, 赵江花, 吕春兰, 等. 3126例血培养结果的细菌学分布及耐药性分析[J]. 检验医学与临床, 2011, 8(12): 1490-1492.
[3]谢琳卡, 杨道峰, 余贻汗, 等. 凝固酶阴性葡萄球菌血流感染临床分析及耐药性检测[J]. 内科危重症杂志, 2007, 13(6): 30-34.
[4]周仲松, 余鑫之, 王中新, 等. 576株血培养分离菌的临床分布及耐药性变迁[J]. 中华临床感染病杂志, 2009, 2(1): 30-34.
[5]黄红卫, 欧阳育琪, 黄强, 等. 148株血流感染大肠埃希菌的耐药性分析[J]. 实用预防医学, 2012, 19(7): 1056-1057.
[6]周祥文, 汪勇军, 吴先华, 等. 导管相关性血流感染患者分离大肠埃希菌的耐药性分析[J]. 中华医院感染学杂志, 2014(2): 292-293.
[7]孙衡, 沈继录, 熊自忠, 等. 临床血标本中产ESBLs大肠埃希菌耐药性检测[J]. 中华医院感染学杂志, 2011(13): 2810-2812
[8]Carmen PO, Rogerio N, Caio M, et al. Multicenter evaluation of resistace patterns of klebsiella pneumoniae, escherichia coli, salmonella spp and shigella spp isolated from clinical specimens in Brazil: RESISTNET Surveillance Program [J]. Braz J Infect Dis, 2001, 5(1): 8-12.
|
| [1] |
. [J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(8): 0-. |
|
|
|
|
2014, Vol. 44 
